Depositary Receipt on ASTS Issued by INVX

Depositary Receipt on ASTS Issued by INVX's next confirmed earnings release is scheduled for November 16, 2026.

As of June 30, 2026, Depositary Receipt on ASTS Issued by INVX has 290.58B shares outstanding.

As of June 30, 2026, Depositary Receipt on ASTS Issued by INVX maintains a current ratio of 13.05, meaning it holds 13.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 124.86, indicating elevated leverage, while an interest coverage ratio of -5.34 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Depositary Receipt on ASTS Issued by INVX posted a negative return on equity (ROE) of -44.82, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.00, reflecting losses generated across the asset base. The company generates approximately 3.87M in revenue per employee across its workforce of 989.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Depositary Receipt on ASTS Issued by INVX recorded 175.11M in income tax expense. The company reported a pretax loss of -26.77B and -20.56B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Depositary Receipt on ASTS Issued by INVX generated 3.83B in revenue and converted that into -20.56B in net income, yielding earnings per share of -0.10. EBITDA reached -13.50B, while operating income came in at -15.72B.

As of June 30, 2026, Depositary Receipt on ASTS Issued by INVX holds 76.03B in cash and equivalents against 99.47B in total debt, resulting in a net debt position of 22.72B. Total book value stands at 62.93B, with working capital of 76.51B providing operational flexibility.

Depositary Receipt on ASTS Issued by INVX produced -4.81B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -52.89B in capital expenditures, free cash flow totaled -57.70B - equivalent to -0.21 per share.

Over the twelve months ended June 30, 2026, Depositary Receipt on ASTS Issued by INVX posted a gross margin of 39.17, reflecting its pricing power and cost economics. The operating margin of -410.26 and net profit margin of -536.66 provide insight into operational efficiency.